1,458 results on '"Benedict, Ralph"'
Search Results
2. Cortical thickness and cognition in older people with multiple sclerosis
3. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial
4. Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study
5. Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
6. Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis
7. Cognitive performance and magnetic resonance imaging in people with multiple sclerosis: A systematic review and meta-analysis
8. The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
9. Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis
10. Internet-delivered lifestyle physical activity intervention for cognitive processing speed in multiple sclerosis
11. Multiple sclerosis
12. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis
13. Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis
14. Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives
15. Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives
16. A validation study for remote testing of cognitive function in multiple sclerosis
17. Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study
18. Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis
19. Time course of lesion-induced atrophy in multiple sclerosis
20. Multiple sclerosis.
21. Patient-Reported Outcome Severity and Emotional Salience Network Disruption in Multiple Sclerosis
22. Functional network dynamics and decreased conscientiousness in multiple sclerosis
23. Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis dataset
24. Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic
25. Correlates of patient-reported cognitive performance with regard to disability
26. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis
27. Eight-point Reliable Change on Symbol Digit Modalities Test with Ozanimod: Findings from the Phase 3 SUNBEAM and DAYBREAK Extension Trials (P6-6.015)
28. Predictive Utility of Serum Protein Biomarkers from the Octave MSDA Panel for Optic Neuritis Events in People with Multiple Sclerosis (S42.008)
29. Contextual Factors Matter: The Role of Social Support in Work-Related Difficulties and Employment Status in Persons with Multiple Sclerosis
30. Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study
31. Personality and Performance in Specific Neurocognitive Domains Among Older Persons
32. Brain MRI atrophy quantification in MS
33. Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?
34. Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study
35. Cognitive function in severe progressive multiple sclerosis.
36. Human restricted CHRFAM7A gene increases brain efficiency.
37. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
38. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy controls
39. Neuropsychological assessment in MS is outdated and in need for innovation: Commentary
40. Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
41. Diagnosis of depression in multiple sclerosis is predicted by frontal–parietal white matter tract disruption
42. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis
43. Multiple sclerosis
44. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis
45. Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study
46. Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures
47. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis.
48. Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speed
49. Detecting isolated cognitive relapses in persons with MS
50. Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.